FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...
FDA approves Omvoh for moderately to severely active Crohn's disease
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
Irish Examiner on MSN1d
Recipes: How you can eat to beat gut inflammation
Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...
Managed Healthcare Executive1d
FDA Approves Lilly’s Omvoh for Crohn's Disease, Second Indication
More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...
Louise Thompson opens up about plans for 'Barbie Butt Surgery'
Made In Chelsea star Louise Thompson has revealed her plans for 'Barbie Butt Surgery' in the future, stemming from her ...
Voice Newspaper3d
Music For the Soul: How one artist pursued her passion while navigating Crohn’s Disease
17,000 people answered the IBD UK Patient Survey, and the results reveal patients are facing long waits at every stage of the ...
PharmiWeb4d
AbbVie’s SKYRIZI® (risankizumab) Accepted by the S…
Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...
Rough Draft Atlanta on MSN5d
Torch Gala aims to raise $800,000 for Crohn’s and Colitis Foundation
The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...